Showing results (1-10 of 782) with videos related to

Sort By:
Pageof 79
Journal of Neurosurgery|October 1, 1993
Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cellsS Kunwar, L H Pai, I Pastan
European Journal of Immunology|June 1, 1997
Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxinsD M Roscoe, L H Pai, I Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndromeC T Kuan, L H Pai, I Pastan
International Journal of Cancer|July 28, 1995
Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude miceI Benhar, Y Reiter, L H Pai, et al.
Breast Cancer Research and Treatment|January 1, 1996
Recombinant immunotoxinsI Pastan, L H Pai, U Brinkmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Alteration of a protease-sensitive region of Pseudomonas exotoxin prolongs its survival in the circulation of miceU Brinkmann, L H Pai, D J FitzGerald, et al.
Cancer Research|August 15, 1992
Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic miceG H Mickisch, L H Pai, M M Gottesman, et al.
Cancer Research|June 1, 1991
Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40)L H Pai, M G Gallo, D J FitzGerald, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in miceU Brinkmann, L H Pai, D J FitzGerald, et al.
Cancer Research|May 15, 1994
Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragmentY Reiter, L H Pai, U Brinkmann, et al.
Pageof 79